These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1412777)

  • 1. Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol.
    Lemire JM; Archer DC; Khulkarni A; Ince A; Uskokovic MR; Stepkowski S
    Transplantation; 1992 Oct; 54(4):762-3. PubMed ID: 1412777
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts.
    Mirisklavos A; Mottram PL; Smith JA; Mason A; Dumble LJ; Clunie GJ; Panagiotopoulos S; Nayler WG
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1259-61. PubMed ID: 3274313
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression with the vitamin D analogue MC 1288 in experimental transplantation.
    Johnsson C; Binderup L; Tufveson G
    Transplant Proc; 1996 Apr; 28(2):888-91. PubMed ID: 8623448
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor bone marrow cell induced prolongation of murine cardiac allografts.
    Hoshinaga K; Mohanakumar T; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):491-3. PubMed ID: 2650183
    [No Abstract]   [Full Text] [Related]  

  • 5. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibiting accelerated rejection mediated by alloreactive CD4(+) memory T cells and prolonging allograft survival by 1α,25-dihydroxyvitamin D(3) in nude mice.
    Yan G; Xi Y; Xu S; Chen J; Lin Y; Dai H; Cheng P; Xiao H; Liu Z; Qi Z
    Immunol Lett; 2013 Jan; 149(1-2):54-61. PubMed ID: 23147102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal induction of tolerance to cardiac allografts.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1994 Feb; 26(1):207-8. PubMed ID: 8108945
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 10. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
    Hamano K; Rawsthorne M; Bushell A; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.
    Morris RE; Wang J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):493-6. PubMed ID: 1990597
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts.
    Fu F; Li Y; Qian S; Lu L; Chambers FD; Starzl TE; Fung JJ; Thomson AW
    Transplant Proc; 1997; 29(1-2):1310. PubMed ID: 9123320
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor alpha chain and beta chain.
    Isobe M; Suzuki J; Okubo Y; Horie S; Tanaka T; Miyasaka M; Sekiguchi M
    Transplant Proc; 1997 Jun; 29(4):2301-2. PubMed ID: 9193630
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.
    Hullett DA; Cantorna MT; Redaelli C; Humpal-Winter J; Hayes CE; Sollinger HW; Deluca HF
    Transplantation; 1998 Oct; 66(7):824-8. PubMed ID: 9798688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of specific unresponsiveness to murine cardiac allografts by intrathymic inoculation of MHC class I allopeptides.
    Chowdhury NC; Jin MX; Athan ES; Hardy MA; Oluwole SF
    Transplant Proc; 1995 Feb; 27(1):237-8. PubMed ID: 7878983
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.